Litchman Manuel MD 4
4 · MUSTANG BIO, INC. · Filed Apr 29, 2021
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Sale
COMMON STOCK
2020-05-22$3.04/sh−8,348$25,378→ 813,035 total - Sale
COMMON STOCK
2020-05-22$3.04/sh−4,025$12,236→ 821,383 total
Footnotes (4)
- [F1]4,025 shares were sold in connection with the vesting of 15,250 shares on March 26, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]8,348 shares were sold in connection with the vesting of 30,500 shares on April 24, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F3]Represents the weighted average sales price.
- [F4]Includes restricted share units, which vest over various time periods.